An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype
✍ Scribed by Parvoneh Poorkaj; Nancy A. Muma; Victoria Zhukareva; Elizabeth J. Cochran; Kathleen M. Shannon; Howard Hurtig; William C. Koller; Thomas D. Bird; John Q. Trojanowski; Virginia M.-Y. Lee; Gerard D. Schellenberg
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 486 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
MAPT, the gene encoding tau, was screened for mutations in 96 progressive supranuclear palsy subjects. A point mutation (^R^5^L^) was identified in a single progressive supranuclear palsy subject that was not in the other progressive supranuclear palsy subjects or in 96 controls. Functionally, this mutation alters the ability of tau to promote microtubule assembly. Analysis of soluble tau from different brain regions indicates that the mutation does not affect the ratio of tau isoforms synthesized. Aggregated insoluble tau from subcortical regions was predominantly four‐repeat tau with no or one amino terminal insert (0N4R and 1N4R). Insoluble tau from cortical regions also contained 1N3R tau. Thus, the ^R^5^L^ mutation causes a progressive supranuclear palsy phenotype, presumably by a gain‐of‐function mechanism.
📜 SIMILAR VOLUMES
The Werner's syndrome ( WS) is a rare recessive disease characterized by an early onset of geriatric disorders. The Werner's syndrome gene ( WRN), recently cloned, encodes for an helicase and therefore plays a role in DNA metabolism and DNA repair. Here, we report the study of a French family with t